Solid Biosciences
Stock Forecast, Prediction & Price Target
Solid Biosciences Financial Estimates
Solid Biosciences Revenue Estimates
Solid Biosciences EBITDA Estimates
Solid Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $13.62M N/A | $8.09M -40.57% | $0 -100% | Avg: $3.80M Low: $3.80M High: $3.80M avg. 0% | Avg: $1.87M Low: $1.87M High: $1.87M avg. -50.72% | Avg: $45.4M Low: $45.4M High: $45.4M avg. 2322.67% | Avg: $166.23M Low: $166.23M High: $166.23M avg. 266.15% |
Net Income
% change YoY
| $-72.12M N/A | $-65.51M 9.17% | $-96.01M -46.56% | Avg: $-117.61M Low: $-72.17M High: $-43.54M avg. -22.49% | Avg: $-148.49M Low: $-72.77M High: $-36.38M avg. -26.25% | Avg: $-58.95M Low: $-58.95M High: $-58.95M avg. 60.29% | Avg: $-19.98M Low: $-19.98M High: $-19.98M avg. 66.10% |
EBITDA
% change YoY
| $-69.29M N/A | $-107.92M -55.75% | $-93.43M 13.42% | Avg: $760.67K Low: $760.67K High: $760.67K avg. 100.81% | Avg: $374.79K Low: $374.79K High: $374.79K avg. -50.72% | Avg: $9.07M Low: $9.07M High: $9.07M avg. 2322.68% | Avg: $33.24M Low: $33.24M High: $33.24M avg. 266.15% |
EPS
% change YoY
| -$10.13 N/A | -$7.7 23.98% | -$4.83 37.27% | Avg: -$2.71 Low: -$3.63 High: -$2.19 avg. 43.99% | Avg: -$2.54 Low: -$3.66 High: -$1.83 avg. 6.06% | Avg: -$2.97 Low: -$2.97 High: -$2.97 avg. -16.67% | Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 66.10% |
Operating Expenses
% change YoY
| $85.87M N/A | $107.36M 25.02% | $104.31M -2.84% | Avg: $6.51M Low: $6.51M High: $6.51M avg. -93.75% | Avg: $3.21M Low: $3.21M High: $3.21M avg. -50.72% | Avg: $77.80M Low: $77.80M High: $77.80M avg. 2322.67% | Avg: $284.88M Low: $284.88M High: $284.88M avg. 266.15% |
FAQ
What is Solid Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.41% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -72.17M, average is -117.61M and high is -43.54M.
What is Solid Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 634.52% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $3.80M, average is $3.80M and high is $3.80M.
What is Solid Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.87% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.63, average is -$2.71 and high is $-2.19.
What is the best performing analyst?
In the last twelve months analysts have been covering Solid Biosciences stock. The most successful analyst is Joseph Schwartz.